Y.K. Hamied, chairman and managing director of Indian generic drugmaker Cipla, speaks on his mobile phone in front of cabinets containing the company's products before an interview in Mumbai May 8, 2012. REUTERS/Vivek Prakash/Files

Reuters
Y.K. Hamied, chairman and managing director of Indian generic drugmaker Cipla, speaks on his mobile phone in front of cabinets containing the company's products before an interview in Mumbai May 8, 2012. REUTERS/Vivek Prakash/Files
Y.K. Hamied, chairman and managing director of Indian generic drugmaker Cipla, speaks on his mobile phone in front of cabinets containing the company's products before an interview in Mumbai May 8, 2012. REUTERS/Vivek Prakash/Files
View Comments (0)